Catalent | CTLT - Aktuelle Verpflichtungen



Aktuelle Verpflichtungen Veränderung Datum
Agilent USD 2.27B 35M 2026-03
AstraZeneca USD 32.57B 1.95B 2026-03
Bristol-Myers Squibb USD 19.16B 4.26B 2026-03
Bruker USD 1.36B 75.9M 2026-03
Centene USD 40.04B 3.35B 2026-03
Charles River Laboratories USD 1.09B 26.61M 2026-03
Cigna USD 52.61B 3.74B 2026-03
Danaher USD 7.46B 653M 2026-03
Dentsply International USD 1.21B 136M 2026-03
Elevance Health USD 45.31B 4.27B 2026-03
Eli Lilly USD 36.63B 1.41B 2026-03
Glaxosmithkline GBP 22.43B 6.39B 2026-03
Humana USD 21.51B 5.16B 2026-03
Illumina USD 1.57B 19M 2026-03
Intuitive Surgical USD 2.51B 3.2M 2026-03
IQVIA Holdings USD 8.33B 9M 2026-03
J&J USD 57.72B 3.59B 2026-03
Laboratory Of America USD 2.64B 182.5M 2026-03
Lonza CHF 3.57B 421M 2025-12
McKesson USD 67.02B 1.11B 2026-03
Merck EUR 9.35B 307M 2026-03
Merck USD 26.94B 1.38B 2026-03
Mettler Toledo International USD 1.11B 89.76M 2026-03
Novartis USD 31.37B 4.1B 2026-03
Pfizer USD 34.35B 2.64B 2026-03
Quest Diagnostics USD 2.18B 101M 2026-03
Repligen USD 126.21M 9.62M 2026-03
Revvity USD 1.24B 92.6M 2026-03
Roche Holding CHF 28B 421M 2025-12
Supernus Pharmaceuticals USD 373.93M 35.76M 2026-03
Thermo Fisher Scientific USD 14.62B 568M 2026-03
UnitedHealth USD 114.12B 773M 2026-03
Veradigm USD 230.31M 22.78M 2022-12
Waters USD 1.24B 11.8M 2025-12
West Pharmaceutical Services USD 674M 19.1M 2026-03